Genomize
PrivateMomentum
Top 25%
of companies Caplight tracks
Company Overview
Genomize operates in Healthcare & Life Sciences and is based in Turkey. It was founded in 2014.
Genomize is a healthtech company that provides a bioinformatics platform designed for genomic data analysis.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Precision Medicine, Healthcare Analytics, Medical AI
Business Model
B2B
Customer Profile
Subscription SaaS, Usage-Based SaaS, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Genomize Comparables
Compare Genomize with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Geneyx | 91% | |
| Euformatics | 87% | |
| SeqOne | 83% |
For institutional investors. Book with your work email.
Genomize Funding Rounds
Historical fundraising activity
Genomize Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ScaleX Ventures | Angel |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 27, 2026
Grew 18% QoQ, from 17 to 20 employees.
- Jul 25, 2026
Monthly visitors increased 291% MoM, reaching 2.7K.
For institutional investors. Book with your work email.
Genomize Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about Genomize's valuation, stock price, and market status.
Is Genomize a public or private company?
Genomize is a private company.
What is the current stock price of Genomize?
Genomize is a private company, so its shares have no public market price. Caplight tracks Genomize's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is Genomize worth (valuation)?
Valuation information for Genomize is not publicly available.
Can I buy Genomize stock?
Genomize shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was Genomize's last funding round?
Funding round information for Genomize is not publicly available.
Who are the main investors in Genomize?
Key investors in Genomize include ScaleX Ventures.
Will Genomize IPO soon?
No public IPO plans have been announced for Genomize.
How can I track Genomize secondary market activity?
Caplight tracks bids, offers, and trades in Genomize's shares on secondary markets.